Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Specialty Minerals, Inc.
EIR
•Specialty Minerals, Inc.•August 22, 2019

Specialty Minerals, Inc. – FDA EIR, Aug 22, 2019

Record Details

An FDA surveillance inspection of Specialty Minerals, Inc. in Adams, MA, conducted from August 19-22, 2019, focused on Good Manufacturing Practice (GMP) compliance for their Active Pharmaceutical Ingredient, Calcium Carbonate USP. The inspection, carried out under established FDA guidance for API and drug manufacturing, identified three significant deficiencies, which were detailed in an FDA-483 observation report. Key violations included incomplete laboratory control records. Specifically, critical data such as sample weights, reagent information, and personnel signatures were absent for elemental testing and solution standardization, compromising data integrity. Secondly, the firm's quality system exhibited a recurring failure to complete customer complaint investigations within the prescribed 30-day timeframe, a repeat observation from a previous 2015 inspection. Lastly, an investigation into a customer's microbial contamination complaint for Calcium Carbonate USP was found inadequate. The company initially overlooked the issue, mistakenly asserting no microbial testing requirement, and failed to adequately assess the contamination source. Additionally, the firm lacked a procedure for handling out-of-trend microbial test results and did not have established limits for microbial enumeration tests. Company management, led by Plant Manager Steven C. Thompson, acknowledged the findings. Mr. Thompson committed to submitting a written response within 15 business days. Quality Assurance Manager Anh Nguyen pledged to correct the laboratory record deficiencies and reopen the microbial complaint for thorough investigation. Other discussions involved updating National Drug Code listings and incorporating microbial trending data into Annual Product Reviews.

Company
Specialty Minerals, Inc.
Inspection date
August 22, 2019
Product type
drugs
Office
New England District Office
People
  • Steven C. Thompson (recipient)
  • Anh Nguyen (company_representative)
  • Darin Lindsey (company_representative)
  • Robert Galisa (company_representative)
  • Nancy M. Espinal (Investigator)
View Company Profile

ID · 1047dc99-ceaa-4c2b-9491-211b75ebece9

Violation Codes1
21 CFR 207.57(c)

Full citation text and observation details available on the Dashboard.

Other documents for Specialty Minerals, Inc.
  • 483 - 2025-09-23September 23, 2025
  • 483 - 2019-08-22August 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Specialty Minerals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.